SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-22-003862
Filing Date
2022-03-22
Accepted
2022-03-22 18:39:00
Documents
1
Period of Report
2022-03-18

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5047
  Complete submission text file 0001387131-22-003862.txt   6490
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2658 DEL MAR HEIGHTS RD., #555 DEL MAR CA 92014
Business Address
Marguglio David J. (Reporting) CIK: 0001461753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 22761085